ENTX vs RVTY · $58.2M cap vs P/E 42, rev $1.44B
Entera Bio Ltd (ENTX) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Entera Bio Ltd (ENTX) is a biotechnology company listed on US.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported ENTX revenue for 2026-06-30 was $0. Net income was -$10.8M. ENTX currently screens at market cap $58.2M.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
ENTX currently screens at market cap $58.2M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the ENTX and RVTY stock pages for the full models.
Not investment advice.